Emilio Yángüez

This study shows PD1-IL2v expands a novel stem-like T cell subset in lymph nodes that enhances effector differentiation, distinct from PD-1 therapy's exhausted state.

The paper compares scRNA-seq protocols for clinical trial samples, finding that GEM-X Flex with chop-fix outperforms standard protocols and snRNA-seq in fixed tissue and FFPE blocks.

HiDRA-seq enables high-throughput, low-cost SARS-CoV-2 testing using barcoded cDNA and NGS, allowing thousands of samples to be sequenced per run.